Discussions and articles surrounding trending topics in the liver industry

Image of liver in yellow

FibroScan vs. Ultrasound Elastography

By All, Blog

A race is under way among pharmaceutical companies to develop drugs that treat a spectrum of liver diseases, including nonalcoholic fatty liver disease (NAFLD), an asymptomatic condition characterized by elevated levels of fat in the liver, and its more severe form, nonalcoholic steatohepatitis (NASH).

Read More